Get the Stockscreener App
1.545
0.32%
0.005
After Hours:
1.55
0.005
+0.32%
Lava Therapeutics Nv stock is traded at $1.545, with a volume of 57,150.
It is up +0.32% in the last 24 hours and up +0.98% over the past month.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.
See More
Previous Close:
$1.54
Open:
$1.54
24h Volume:
57,150
Relative Volume:
0.64
Market Cap:
$40.64M
Revenue:
$9.06M
Net Income/Loss:
$-50.39M
P/E Ratio:
-0.8047
EPS:
-1.92
Net Cash Flow:
$5.89M
1W Performance:
-1.59%
1M Performance:
+0.98%
6M Performance:
+14.44%
1Y Performance:
-8.25%
1-Day Range:
$1.53
$1.5554
1-Week Range:
$1.53
$1.58
52-Week Range:
$0.8502
$2.093
Lava Therapeutics Nv Stock (LVTX) Company Profile
Name
Lava Therapeutics Nv
Sector
Industry
Phone
31 6 3000 3035
Address
YALELAAN 62, UTRECHT
Compare LVTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LVTX
Lava Therapeutics Nv
|
1.545 | 41.17M | 9.06M | -50.39M | 5.89M | -1.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Lava Therapeutics Nv Stock (LVTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-12-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Dec-11-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Oct-25-22 | Initiated | H.C. Wainwright | Buy |
| Apr-19-21 | Initiated | JP Morgan | Overweight |
| Apr-19-21 | Initiated | Jefferies | Buy |
| Apr-19-21 | Initiated | SVB Leerink | Outperform |
View All
Lava Therapeutics Nv Stock (LVTX) Latest News
Should you wait for a breakout in LAVA Therapeutics N.V.Buy Signal & Free Community Supported Trade Ideas - Newser
Combining machine learning predictions for LAVA Therapeutics N.V.July 2025 Catalysts & High Accuracy Swing Trade Signals - Newser
Real time alert setup for LAVA Therapeutics N.V. performanceMarket Movers & Low Drawdown Momentum Ideas - Newser
Is LAVA Therapeutics N.V. a candidate for recovery play2025 Price Targets & Low Drawdown Investment Strategies - Newser
Strategies to average down on LAVA Therapeutics N.V.Quarterly Growth Report & Verified Short-Term Trading Plans - Newser
Is LAVA Therapeutics N.V. stock entering bullish territory2025 Short Interest & Community Trade Idea Sharing - Newser
Will LAVA Therapeutics N.V. benefit from macro trendsMarket Trend Summary & Smart Allocation Stock Tips - Newser
Using data tools to time your LAVA Therapeutics N.V. exitJuly 2025 Short Interest & Safe Capital Growth Stock Tips - Newser
Will LAVA Therapeutics N.V. bounce back from current supportPortfolio Return Summary & Low Drawdown Momentum Ideas - Newser
Chart based analysis of LAVA Therapeutics N.V. trends2025 Volatility Report & Low Drawdown Trading Techniques - Newser
Detecting price anomalies in LAVA Therapeutics N.V. with AIAnalyst Downgrade & Fast Entry and Exit Trade Plans - Newser
Leading vs lagging indicators on LAVA Therapeutics N.V. performanceJuly 2025 Analyst Calls & AI Enhanced Trading Signals - Newser
Building trade automation scripts for LAVA Therapeutics N.V.Forecast Cut & AI Based Buy and Sell Signals - Newser
Earnings visualization tools for LAVA Therapeutics N.V.2025 Retail Activity & Real-Time Stock Entry Alerts - Newser
How moving averages guide LAVA Therapeutics N.V. tradingEarnings Growth Report & Low Drawdown Investment Ideas - Newser
LAVA Therapeutics N.V. stock trendline breakdownTrade Analysis Summary & Technical Confirmation Trade Alerts - Newser
Analyzing LAVA Therapeutics N.V. with multi timeframe charts2025 Big Picture & Free AI Powered Buy and Sell Recommendations - Newser
Can swing trading help recover from LAVA Therapeutics N.V. losses2025 Volatility Report & Weekly Hot Stock Watchlists - Newser
Can momentum traders help lift LAVA Therapeutics N.V.Weekly Trade Report & Weekly Sector Rotation Insights - Newser
Published on: 2025-09-11 03:12:55 - Newser
Using RSI to spot recovery in LAVA Therapeutics N.V.2025 Top Decliners & AI Based Buy and Sell Signals - Newser
Forecasting LAVA Therapeutics N.V. price range with options data2025 EndofYear Setup & Step-by-Step Swing Trade Plans - Newser
Using fundamentals and technicals on LAVA Therapeutics N.V.Breakout Watch & Weekly Chart Analysis and Guides - Newser
Is LAVA Therapeutics N.V. forming a double bottomProfit Target & Safe Capital Allocation Plans - Lancaster City Council
detecting price anomalies in lava therapeutics n.v. with aiJuly 2025 Selloffs & Expert-Curated Trade Recommendations - Newser
LAVA Therapeutics N.V. stock trend outlook and recovery pathPortfolio Risk Report & Safe Swing Trade Setup Alerts - Newser
Live market analysis of LAVA Therapeutics N.V.Trade Analysis Report & AI Enhanced Trading Signals - Newser
Combining price and volume data for LAVA Therapeutics N.V.Earnings Trend Report & Long Hold Capital Preservation Plans - Newser
Chart based exit strategy for LAVA Therapeutics N.V.Stop Loss & Stepwise Swing Trade Plans - Newser
Lava Therapeutics Nv Stock (LVTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):